Ocrevus
List of products in the National Drug Code with proprietary name ocrevus. Ocrelizumab is used to treat certain forms of multiple sclerosis-MS (relapsing or primary progressive forms). It is not a cure for MS, but it is thought to help slow down nerve damage, reduce the number of relapses, and delay disability. Ocrelizumab belongs to a class of drugs known as monoclonal antibodies.
| NDC | Proprietary Name | Non-Proprietary Name | Dosage Form | Route Name | Labeler Name | Product Type |
|---|---|---|---|---|---|---|
| 50242-150 | Ocrevus | Ocrelizumab | Injection | Intravenous | Genentech, Inc. | Human Prescription Drug |
